Bowhead Specialty 3Q 2026: Revenue $171.8M, Net income $12.9M, EPS $0.38— 10-Q Summary

What happened

Bowhead Specialty Holdings reported third-quarter 2026 revenue of $171.8 million, up 19.3% from a year earlier. Net income fell 14.7% to $12.9 million, and diluted EPS declined to $0.38 from $0.45, as merger-related expenses weighed on earnings.

Confirmed

Global impact / market context

Revenue grew while profit fell, so the company kept less of each sales dollar, which means profit per sale shrank. Higher merger-related expenses and a larger share of premiums ceded to reinsurers reduce the money Bowhead retains, so investors should judge whether growth creates profit.

Analyst inference

Gross premiums rose 20.7% over nine months to $771.1 million, with excess and surplus lines, which means coverage for unusual risks, at 81.5% of that total. Bowhead also raised its quota-share reinsurance cession, the share of premiums passed to reinsurers, to 33.5% in May 2026.

Analyst inference

What to watch

1. Watch whether merger-related expenses persist in coming quarters, since they contributed to the 14.7% net income decline even as revenue rose 19.3% to $171.8 million. Confirmed
2. Management should clarify how the higher 33.5% quota-share reinsurance cession affects future revenue retained and profit, given it passes more premiums to reinsurers. Proposed
3. Track Baleen Specialty premium growth, up 233.4% to $41.1 million, and casualty growth, since these drove nine-month gross premiums and may shape future earnings if costs stay controlled. Analyst inference

Evidence

• Original source link unavailable